The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression | Zendy

Jared Cooney Horvath | Zendy; John Mathews | Zendy; Mark A. Demitrack | Zendy; Álvaro PascualLeone | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression

Author(s) -

Jared Cooney Horvath,

John Mathews,

Mark A. Demitrack,

Álvaro PascualLeone

Publication year - 2010

Publication title -

journal of visualized experiments

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.596

H-Index - 91

ISSN - 1940-087X

DOI - 10.3791/2345-v

Subject(s) - medicine , transcranial magnetic stimulation , depression (economics) , clinical trial , randomized controlled trial , treatment resistant depression , population , antidepressant , major depressive episode , rating scale , clinical global impression , dorsolateral prefrontal cortex , electroconvulsive therapy , psychiatry , prefrontal cortex , psychology , stimulation , schizophrenia (object oriented programming) , mood , placebo , alternative medicine , hippocampus , pathology , developmental psychology , cognition , environmental health , economics , macroeconomics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research